Immune features of the peritumoral stroma in pancreatic ductal adenocarcinoma
暂无分享,去创建一个
N. Halama | D. Jäger | N. Giese | C. Springfeld | Azaz Ahmed | R. Klotz | Thilo Hackert | S. Köhler | T. Hackert
[1] N. Halama,et al. Tertiary lymphoid structures and their association to immune phenotypes and circulatory IL2 levels in pancreatic ductal adenocarcinoma , 2022, Oncoimmunology.
[2] A. Jemal,et al. Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.
[3] N. Halama,et al. Combined inhibition of CXCL12 and PD-1 in MSS colorectal and pancreatic cancer: modulation of the microenvironment and clinical effects , 2021, Journal for ImmunoTherapy of Cancer.
[4] Y. S. Zhang,et al. 3D-bioprinted cancer-on-a-chip: level-up organotypic in vitro models. , 2021, Trends in biotechnology.
[5] Yunmei Song,et al. Three-Dimensional Printing for Cancer Applications: Research Landscape and Technologies , 2021, Pharmaceuticals.
[6] B. Verrier,et al. Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins , 2021, Frontiers in Immunology.
[7] A. Chandrasekaran,et al. A novel tumor-immune microenvironment (TIME)-on-Chip mimics three dimensional neutrophil-tumor dynamics and neutrophil extracellular traps (NETs)-mediated collective tumor invasion , 2021, Biofabrication.
[8] N. Halama,et al. Peripheral blood and tissue assessment highlights differential tumor-circulatory gradients of IL2 and MIF with prognostic significance in resectable pancreatic ductal adenocarcinoma , 2021, Oncoimmunology.
[9] N. Halama. Bowel inflammation in cancer patients: the microbiome, antibiotics and interleukin-9 , 2020, British Journal of Cancer.
[10] L. Apetoh. Anticancer effects of the microbiota: how the microbiome shapes the development of IL-9-producing T cells , 2020, British Journal of Cancer.
[11] N. Câmara,et al. Host dysbiosis negatively impacts IL-9-producing T-cell differentiation and antitumour immunity , 2020, British Journal of Cancer.
[12] G. Sukhikh,et al. Macrophage Modification Strategies for Efficient Cell Therapy , 2020, Cells.
[13] Ling-ling Sun,et al. Th9 Cell Differentiation and Its Dual Effects in Tumor Development , 2020, Frontiers in Immunology.
[14] R. Flavell,et al. IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy , 2020, Nature.
[15] M. Karamouzis,et al. Immunotherapy for pancreatic cancer: A 2020 update. , 2020, Cancer treatment reviews.
[16] Yong Lu,et al. Targeting the IL-9 pathway in cancer immunotherapy , 2020, Human vaccines & immunotherapeutics.
[17] Michelle A. Anderson,et al. Regulatory T cell depletion alters the tumor microenvironment and accelerates pancreatic carcinogenesis. , 2020, Cancer discovery.
[18] J. D'haese,et al. The role of interleukin-18 in pancreatitis and pancreatic cancer. , 2019, Cytokine & growth factor reviews.
[19] Shanyu Qin,et al. Targeted blockade of interleukin 9 inhibits tumor growth in murine model of pancreatic cancer. , 2019, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.
[20] K. Nakanishi. Unique Action of Interleukin-18 on T Cells and Other Immune Cells , 2018, Front. Immunol..
[21] C. Denkert,et al. Cytotoxic tumour-infiltrating T lymphocytes influence outcome in resected pancreatic ductal adenocarcinoma. , 2017, European journal of cancer.
[22] Laurence Zitvogel,et al. The immune contexture in cancer prognosis and treatment , 2017, Nature Reviews Clinical Oncology.
[23] Bang-li Hu,et al. Interleukin-9 Promotes Pancreatic Cancer Cells Proliferation and Migration via the miR-200a/Beta-Catenin Axis , 2017, BioMed research international.
[24] R. Qin,et al. Blocking NF-κB Is Essential for the Immunotherapeutic Effect of Recombinant IL18 in Pancreatic Cancer , 2016, Clinical Cancer Research.
[25] M. Koch,et al. Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients. , 2016, Cancer cell.
[26] I. Amit,et al. Microbiota-Modulated Metabolites Shape the Intestinal Microenvironment by Regulating NLRP6 Inflammasome Signaling , 2015, Cell.
[27] Zhiqiang Liu,et al. Tumor-specific Th2 responses inhibit growth of CT26 colon-cancer cells in mice via converting intratumor regulatory T cells to Th9 cells , 2015, Scientific Reports.
[28] K. Xie,et al. Pancreatic cancer stromal biology and therapy , 2015, Genes & diseases.
[29] N. Murray,et al. Complex role for the immune system in initiation and progression of pancreatic cancer. , 2014, World journal of gastroenterology.
[30] S. Goerdt,et al. Macrophage activation and polarization: nomenclature and experimental guidelines. , 2014, Immunity.
[31] Umar Mahmood,et al. Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival. , 2014, Cancer cell.
[32] Benjamin D. Smith,et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.
[33] Yuhuan Zheng,et al. Tumor-specific IL-9–producing CD8+ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers , 2014, Proceedings of the National Academy of Sciences.
[34] Y. Miao,et al. Role of CXCL12/CXCR4 signaling axis in pancreatic cancer , 2013, Chinese medical journal.
[35] Mingli Yuan,et al. Differentiation and immune regulation of IL-9-producing CD4+ T cells in malignant pleural effusion. , 2012, American journal of respiratory and critical care medicine.
[36] Alexander A. Fingerle,et al. The role of stroma in pancreatic cancer: diagnostic and therapeutic implications , 2012, Nature Reviews Gastroenterology &Hepatology.
[37] C. Sautès-Fridman,et al. The immune contexture in human tumours: impact on clinical outcome , 2012, Nature Reviews Cancer.
[38] Axel Benner,et al. Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy. , 2011, Cancer research.
[39] M. Kloor,et al. Quantification of prognostic immune cell markers in colorectal cancer using whole slide imaging tumor maps. , 2010, Analytical and quantitative cytology and histology.
[40] A. Singh,et al. CXCL12–CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy , 2010, British Journal of Cancer.
[41] C. Compton,et al. The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM , 2010, Annals of Surgical Oncology.
[42] Niels Grabe,et al. Estimation of Immune Cell Densities in Immune Cell Conglomerates: An Approach for High-Throughput Quantification , 2009, PloS one.
[43] C. Robino,et al. IL-18 Paradox in Pancreatic Carcinoma: Elevated Serum Levels of Free IL-18 are Correlated With Poor Survival , 2009, Journal of immunotherapy.
[44] J. Renauld,et al. IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells , 2009, Proceedings of the National Academy of Sciences.
[45] J. Kirkwood,et al. A phase 2, randomized study of SB‐485232, rhIL‐18, in patients with previously untreated metastatic melanoma , 2009, Cancer.
[46] N. Zeps,et al. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] A. Koch,et al. Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways. , 2007, Arthritis and rheumatism.
[48] Eun-Young Kim,et al. Intratumoral delivery of IL-18 naked DNA induces T-cell activation and Th1 response in a mouse hepatic cancer model , 2007, BMC Cancer.
[49] P. Allavena,et al. Increased Survival, Proliferation, and Migration in Metastatic Human Pancreatic Tumor Cells Expressing Functional CXCR4 , 2004, Cancer Research.
[50] M. Imamura,et al. CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer. , 2004, Molecular cancer therapeutics.
[51] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[52] M. Eberl,et al. IL-18 potentiates the adjuvant properties of IL-12 in the induction of a strong Th1 type immune response against a recombinant antigen. , 2000, Vaccine.
[53] L. Liotta,et al. Laser Capture Microdissection , 1996, Science.